Israel’s MeMed Wins FDA Breakthrough Status for AI-Powered Infection Test
Haifa-based MeMed's AI-powered MeMed BV Flex test, distinguishing bacterial from viral infections in 15 minutes, earns FDA Breakthrough Device Designation.
MeMed
Israeli Biotech MeMed Receives $2M Grant for AI-Driven Diagnostics Biobank
Israeli biotech MeMed receives $2 million grant for AI-driven diagnostics biobank to accelerate development of high-risk patient tools.
Navigation